Indena to highlight expanded HPAPI, ADC and peptide drug conjugate capabilities at DCAT Week 2026
Italian CDMO Indena will showcase its high-potency API manufacturing expertise and growing oncology-focused capabilities at DCAT Week in New York, including ten commercial HPAPIs in production and advancing work in antibody-drug and peptide drug conjugates